Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AV Node Isolation in Atrial Fibrillation vs. Modulation by "Pace and Ablate" Strategy

NCT04859933 is registered in ClinicalTrials.gov with Heart and Diabetes Center North-Rhine Westfalia as lead sponsor.

NCT NCT04859933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04859933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AV Node Isolation in Atrial Fibrillation vs. Modulation by "Pace and Ablate" Strategy
Lead sponsor
Heart and Diabetes Center North-Rhine Westfalia
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
February 28, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, av node ablation, escape; rhythm